F11R and colorectal carcinoma: In order to investigate whether loss of JAM-A influences cell motility and migration in CRC, we silenced JAM-A in the Caco-2 CRC cell line using a conditional doxycycline-inducible lentiviral JAM-A shRNA silencing construct.